title: Comparison of Success of Clomiphene citrate and Letrozole in Ovulation Induction.
abstract: The study was carried out to evaluate which drug is better in ovulation induction between clomiphene citrate and letrozole. The study was carried out in the infertility unit of Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka and Centre for Assisted Reproduction (CARE) at Bangladesh Institute of Research and Rehabilitation in Diabetes Endocrine and Metabolic Disorders (BIRDEM), Dhaka from January 2007 to December 2007. One hundred and sixty five cases were taken for the study. It was a prospective interventional comparative study of clomiphene citrate and letrozole in infertile cases. The patients were divided into three groups. Group I--newly detected cases of sub fertility studied with clomiphene citrate. Group II--clomiphene citrate resistant cases studied with letrozole, Group III--newly detected cases of sub fertility studied with letrozole. The cases were followed up for outcome; (ovulation). The TVS was done on 12th or 13th day of menstruation and level of serum progesterone on 21st day of menstrual cycle to see the evidence of ovulation. Endometrial thickness was also measured. The data was collected on a predesigned questionnaire. The variables that influenced the study were-age, occupation, socioeconomic status, menstrual cycle, marital age, parity, history of MR, history of abortion, past medical and surgical history. In the current study it was observed that the signs of ovulation were significantly (p<0.05) higher in Group I treated with clomiphene citrate in comparison to Group II clomiphene citrate resistant cases treated with letrozole. The rate of ovulation was higher in Group I than that of Group III treated with letrozole, but the difference was not statistically significant (p>0.05). The signs of ovulation were present in 45(81.8%) cases in Group I, 33(60.0%) cases in Group II and 37(67.3%) cases in Group III. This findings of the study suggested that clomiphene citrate is higher successful than letrozole though not statistically significant. Letrozole can be preferred in clomiphene citrate resistant cases before starting other expensive therapies.
authors.affiliation: Dr Joysree Saha, Assistant Professor, Department of Gynaecology and Obstetrics, Popular Medical College Hospital, Dhaka, Bangladesh.
authors.forename: J
authors.initials: J
authors.lastname: Saha
authors.forename: S
authors.initials: S
authors.lastname: Akhter
authors.forename: I
authors.initials: I
authors.lastname: Prasad
authors.forename: S
authors.initials: S
authors.lastname: Siddiq
mesh_terms: D000328:Adult; D001459:Bangladesh; D002996:Clomiphene / Q000494:pharmacology*; D005260:Female; D005300:Fertility Agents, Female / Q000494:pharmacology*; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy; D000077289:Letrozole; D009570:Nitriles / Q000494:pharmacology*; D010062:Ovulation Induction; D011446:Prospective Studies; D014230:Triazoles / Q000494:pharmacology*; D055815:Young Adult
chemical_list: D005300:Fertility Agents, Female; D009570:Nitriles; D014230:Triazoles; D002996:Clomiphene; D000077289:Letrozole